Key result
Both marked improvement and worsening in eGFR after mechanical circulatory support were associated with increased mortality.
Cohort (n=3,363)
Yes
Answers are grounded in this paper and cite their sources.
BACKGROUND: The long-term durability and prognostic significance of improvement in renal function after mechanical circulatory support (MCS) has yet to be characterized in a large multicenter population. The primary goals of this analysis were to describe serial post-MCS changes in estimated glomerular filtration rate (eGFR) and determine their association with all-cause mortality. METHODS AND RESULTS: Adult patients enrolled in the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) with serial creatinine levels available (n=3363) were studied. Early post-MCS, eGFR improved substantially (median improvement, 48.9%; P<0.001) with 22.3% of the population improving their eGFR by ≥100% within the first few weeks. However, in the majority of patients, this improvement was transient, and by 1 year, eGFR was only 6.7% above the pre-MCS value (P<0.001). This pattern of early improvement followed by deterioration in eGFR was observed with both pulsatile and continuous-flow devices. Interestingly, poor survival was associated with both marked improvement (adjusted hazard ratio [HR], 1.64; 95% confidence interval [CI], 1.19-2.26; P=0.002) and worsening in eGFR (adjusted HR, 1.63; 95% CI, 1.15-2.13; P=0.004). CONCLUSIONS: Post-MCS, early improvement in renal function is common but seems to be largely transient and not necessarily indicative of an improved prognosis. This pattern was observed with both pulsatile and continuous-flow devices. Additional research is necessary to better understand the mechanistic basis for these complex post-MCS changes in renal function and their associated survival disadvantage. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00119834.
No takes yet. Share an insight, caveat, or question.
Brisco et al. (2013) conducted a cohort in Patients undergoing mechanical circulatory support (MCS) (n=3,363). Marked improvement or worsening in post-MCS eGFR vs. Stable post-MCS eGFR was evaluated on All-cause mortality (HR 1.64, 95% CI 1.19-2.26, p=0.002). Both marked improvement and worsening in eGFR after mechanical circulatory support were associated with increased mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: